Lysophosphatidylcholine and lysophosphatidic acid as key messengers in atherosclerosis: from a lipid-inflammation vicious cycle to therapeutic translation - Quiz - MDSpire

Lysophosphatidylcholine and lysophosphatidic acid: pivotal signaling molecules in atherosclerosis and their potential for therapeutic application

  • By

  • Xue Guan

  • Zhongyan Li

  • Huan Cheng

  • Jingru Li

  • Najie Wen

  • Luqiao Wang

  • July 21, 2026

Share

Original Source(s)

Lysophosphatidylcholine and lysophosphatidic acid as key messengers in atherosclerosis: from a lipid-inflammation vicious cycle to therapeutic translation

  • by Xue Guan, Zhongyan Li, Huan Cheng, Jingru Li, Najie Wen, Luqiao Wang

  • July 21, 2026

Related Content

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy

Effects of HIIT and MICT on cardiovascular function in essential hypertension: roles of inflammation, oxidative stress, and RAS axis

Correction: Trends in mortality and major adverse cardiovascular events following incident acute myocardial infarction